Hi Glutten,
I agree that management has put us between a rock & a hard place, and there may be little difference in the MT as to who prevails.
Having two companies competing is favourable. No improved offer from Z as yet. Just another indication of what a mess management has made of the project.
Z negotiating down after the first tranche, hiding behind Chinese Govt determination of value is my biggest concern. This is not a factor with RSG.
Agreed few conversion notes may be taken up, and that RSG undoubtedly will act in their own best interests. 8% sounds good. Guessing capitalised for first 12 months means no income for first 12 months. Unrenounceable meaning can't be bought, sold or tansfered. Unsecured? RSG underwrites. If buying notes and things don't go well, can the notes be worthless? RSG mentions downside protection. Are you able to explain this please?
As with 99% of shareholders, seriously under water. Agreed to increase our exposure may best be done on further weakness. If Chinese govt approval is with-held, that weakness will be significant......
- Forums
- ASX - By Stock
- i'm in favour of the z deal
ACF
acrow limited
Add to My Watchlist
2.53%
!
$1.02

Hi Glutten, I agree that management has put us between a rock &...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.025(2.53%) |
Mkt cap ! $312.5M |
Open | High | Low | Value | Volume |
99.0¢ | $1.02 | 99.0¢ | $448.9K | 447.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 8010 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 3548 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 8010 | 1.000 |
1 | 11929 | 0.995 |
1 | 5000 | 0.990 |
1 | 990 | 0.980 |
2 | 26544 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 19000 | 2 |
1.030 | 9784 | 1 |
1.035 | 30000 | 1 |
1.050 | 27685 | 3 |
1.055 | 20098 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ACF (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online